Blood Lead Levels and Risk of Deaths from Cardiovascular Disease
Related Experiment Video
Updated: Sep 28, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Madison Kathleen Cook1, Jian Zhang2, Yudan Wei3
1MD Program, Mercer University School of Medicine, Macon, Georgia.
Abstract:
Environmental exposure could be an important modifiable risk factor for cardiovascular disease (CVD). In this study, we investigated the relation between lead exposure, measured as blood lead levels (BLLs) and CVD mortality in a national cohort. A total of 15,036 adults aged ≥19 who participated in the National Health and Nutrition Examination Survey (1988 to 1994) as the baseline examination were followed up through December 31, 2010. Adjusted hazard ratios (HRs) derived from Cox proportional hazard regressions were used to estimate the risk of dying from CVD in association with BLLs. Cardiovascular mortality was 3.76, 8.11, and 14.77 per 1,000 person-years for patients in low, moderate, and high BLLs, respectively. After adjusting for potential confounders, patients in the high lead level had a significantly increased risk of death from all CVD (HR 1.35, 95% confidence interval 1.03 to 1.77), compared with those with low level. Participants in both moderate and high lead levels showed a significantly increased risk of death from heart disease, with an HR of 1.37 (1.04 to 1.81) and 1.60 (1.21 to 2.13), respectively. A significant linear association with all CVD and heart disease deaths was also seen with an HR of 1.08 (1.00 to 1.16) and 1.09 (1.02 to 1.16), respectively, per 1-unit increase in BLLs. In conclusion, the study demonstrates that increasing BLLs were associated with an increased risk of cardiovascular deaths, especially from heart disease. This further supports the possible cardiovascular effects that lead poses on patients at low levels of exposure and the importance of further reducing lead exposure in the general population.
More Related Videos
07:20Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Factors affecting Blood pressure
Physiological Factors:
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...